Crystal structure of the GLP-1 receptor bound to a peptide agonist
Ali Jazayeri,
Mathieu Rappas,
Alastair J. H. Brown,
James Kean,
James C. Errey,
Nathan J. Robertson,
Cédric Fiez-Vandal,
Stephen P. Andrews,
Miles Congreve,
Andrea Bortolato,
Jonathan S. Mason,
Asma H. Baig,
Iryna Teobald,
Andrew S. Doré,
Malcolm Weir,
Robert M. Cooke and
Fiona H. Marshall ()
Additional contact information
Ali Jazayeri: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Mathieu Rappas: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Alastair J. H. Brown: Heptares Therapeutics Ltd, BioPark, Broadwater Road
James Kean: Heptares Therapeutics Ltd, BioPark, Broadwater Road
James C. Errey: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Nathan J. Robertson: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Cédric Fiez-Vandal: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Stephen P. Andrews: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Miles Congreve: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Andrea Bortolato: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Jonathan S. Mason: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Asma H. Baig: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Iryna Teobald: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Andrew S. Doré: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Malcolm Weir: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Robert M. Cooke: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Fiona H. Marshall: Heptares Therapeutics Ltd, BioPark, Broadwater Road
Nature, 2017, vol. 546, issue 7657, 254-258
Abstract:
Abstract Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas. GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes. To gain insight into the molecular mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist. The peptide agonist retains an α-helical conformation as it sits deep within the receptor-binding pocket. The arrangement of the transmembrane helices reveals hallmarks of an active conformation similar to that observed in class A receptors. Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.
Date: 2017
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/nature22800 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:546:y:2017:i:7657:d:10.1038_nature22800
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature22800
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().